Isradipine enhancement of virtual reality cue exposure for smoking cessation: Rationale and study protocol for a double-blind randomized controlled trial

Cigarette smoking remains a leading cause of preventable death in the United States, contributing to over 480,000 deaths each year. Although significant strides have been made in the development of effective smoking cessation treatments, most established interventions are associated with high relapse rates. One avenue for increasing the effectiveness of smoking cessation interventions is to design focused, efficient, and rigorous experiments testing engagement of well-defined mechanistic targets.

Source: Contemporary Clinical Trials - April 22, 2020 Category: Radiology Authors: Santiago Papini, Cara C. Young, Catherine S. Gebhardt, Alex Perrone, Hitoshi Morikawa, Michael W. Otto, John D. Roache, Jasper A.J. Smits Source Type: research